LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.13 | 21.74 | 733 | 496 | 1.4768 | 1.1804 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.13 | 21.74 | 1 | 496 | 0.0020 | -0.4945 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.13 | 21.74 | 938 | 496 | 1.8898 | 1.3029 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.10 | 21.74 | 2 | 540 | 0.0037 | -0.4022 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.10 | 21.74 | 739 | 540 | 1.3662 | 1.1392 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.10 | 21.74 | 2 | 540 | 0.0037 | -0.4022 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.10 | 21.74 | 964 | 540 | 1.7821 | 1.2654 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.07 | 21.74 | 1 | 597 | 0.0017 | -0.4748 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.07 | 21.74 | 743 | 597 | 1.2428 | 1.0930 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.07 | 21.74 | 1 | 597 | 0.0017 | -0.4748 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.07 | 21.74 | 953 | 597 | 1.5940 | 1.2049 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.04 | 21.74 | 4 | 750 | 0.0053 | -0.2820 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.04 | 21.74 | 755 | 750 | 1.0059 | 1.0023 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.04 | 21.74 | 1 | 750 | 0.0013 | -0.4526 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.04 | 21.74 | 968 | 750 | 1.2897 | 1.1021 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 20.01 | 21.74 | 2 | 901 | 0.0022 | -0.3585 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 20.01 | 21.74 | 743 | 901 | 0.8238 | 0.9292 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 20.01 | 21.74 | 2 | 901 | 0.0022 | -0.3585 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 20.01 | 21.74 | 973 | 901 | 1.0788 | 1.0284 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 21.98 | 21.74 | 1 | 1108 | 0.0009 | -0.4189 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 21.98 | 21.74 | 747 | 1108 | 0.6740 | 0.8656 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 21.98 | 21.74 | 2 | 1108 | 0.0018 | -0.3434 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 21.98 | 21.74 | 966 | 1108 | 0.8716 | 0.9521 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 23.95 | 21.74 | 1 | 1354 | 0.0007 | -0.4034 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 23.95 | 21.74 | 748 | 1354 | 0.5522 | 0.8104 | MN20160310_N01 | E13 |